Cargando…
Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP
BACKGROUND: For the pharmacological treatment of bipolar depression several guidelines exist. It is largely unknown, to what extent the prescriptions in daily clinical routine correspond to these evidence based recommendations and which combinations of psychotropic drugs are frequently used. METHODS...
Autores principales: | Haeberle, Anne, Greil, Waldemar, Russmann, Stefan, Grohmann, Renate |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514299/ https://www.ncbi.nlm.nih.gov/pubmed/22998655 http://dx.doi.org/10.1186/1471-244X-12-153 |
Ejemplares similares
-
Drug-Induced Liver Injury during Antidepressant Treatment: Results of AMSP, a Drug Surveillance Program
por: Friedrich, Michaela-Elena, et al.
Publicado: (2015) -
Antipsychotic drug-induced neutropenia: results from the AMSP drug surveillance program between 1993 and 2016
por: Glocker, Catherine, et al.
Publicado: (2023) -
Sex differences in pharmacological treatment of major depressive disorder: results from the AMSP pharmacovigilance program from 2001 to 2017
por: Seifert, Johanna, et al.
Publicado: (2021) -
Suicidal Ideation and Suicidal Behavior as Rare Adverse Events of Antidepressant Medication: Current Report from the AMSP Multicenter Drug Safety Surveillance Project
por: Stübner, Susanne, et al.
Publicado: (2018) -
Cardiovascular Adverse Reactions During Antipsychotic Treatment: Results of AMSP, A Drug Surveillance Program Between 1993 and 2013
por: Friedrich, Michaela-Elena, et al.
Publicado: (2019)